Literature DB >> 7977052

Cardiac involvement in myotonic dystrophy.

P V Fragola1, M Luzi, L Calò, G Antonini, M Borzi, D Frongillo, D Cannata.   

Abstract

Entities:  

Mesh:

Year:  1994        PMID: 7977052     DOI: 10.1016/0002-9149(94)90864-8

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


× No keyword cloud information.
  13 in total

1.  Is it possible to identify infrahissian cardiac conduction abnormalities in myotonic dystrophy by non-invasive methods?

Authors:  D Babuty; L Fauchier; D Tena-Carbi; P Poret; J Leche; M Raynaud; J P Fauchier; P Cosnay
Journal:  Heart       Date:  1999-11       Impact factor: 5.994

2.  Progressive atrioventricular conduction block in a mouse myotonic dystrophy model.

Authors:  C I Berul; C T Maguire; J Gehrmann; S Reddy
Journal:  J Interv Card Electrophysiol       Date:  2000-06       Impact factor: 1.900

3.  Does cytosine-thymine-guanine (CTG) expansion size predict cardiac events and electrocardiographic progression in myotonic dystrophy?

Authors:  N R Clarke; A D Kelion; J Nixon; D Hilton-Jones; J C Forfar
Journal:  Heart       Date:  2001-10       Impact factor: 5.994

4.  Cardiovascular Complications of Neuromuscular Disorders.

Authors:  Bhavesh Sachdev; Perry M. Elliott; William J. McKenna
Journal:  Curr Treat Options Cardiovasc Med       Date:  2002-04

5.  Clinical predictors of conduction disease progression in type I myotonic muscular dystrophy.

Authors:  Saman Nazarian; Kathryn R Wagner; Brian S Caffo; Gordon F Tomaselli
Journal:  Pacing Clin Electrophysiol       Date:  2010-10-14       Impact factor: 1.976

6.  DMPK dosage alterations result in atrioventricular conduction abnormalities in a mouse myotonic dystrophy model.

Authors:  C I Berul; C T Maguire; M J Aronovitz; J Greenwood; C Miller; J Gehrmann; D Housman; M E Mendelsohn; S Reddy
Journal:  J Clin Invest       Date:  1999-02       Impact factor: 14.808

7.  Analysis of Single Nucleotide Polymorphisms (SNPs) of the small-conductance calcium activated potassium channel (SK3) gene as genetic modifier of the cardiac phenotype in myotonic dystrophy type 1 patients.

Authors:  F Rinaldi; A Botta; L Vallo; G Contino; A Morgante; R Iraci; C Catalli; G Silvestri; V M Ventriglia; L Politano; G Novelli
Journal:  Acta Myol       Date:  2008-12

8.  Characterization of cardiac conduction system abnormalities in mice with targeted disruption of Six5 gene.

Authors:  Hiroko Wakimoto; Colin T Maguire; Megan C Sherwood; Marcel M Vargas; Partha S Sarkar; Jennifer Han; Sita Reddy; Charles I Berul
Journal:  J Interv Card Electrophysiol       Date:  2002-10       Impact factor: 1.900

9.  Cytoplasmic CUG RNA foci are insufficient to elicit key DM1 features.

Authors:  Warunee Dansithong; Cordula M Wolf; Partha Sarkar; Sharan Paul; Andy Chiang; Ian Holt; Glenn E Morris; Dorothy Branco; Megan C Sherwood; Lucio Comai; Charles I Berul; Sita Reddy
Journal:  PLoS One       Date:  2008-12-18       Impact factor: 3.240

10.  Loss of muscleblind-like 1 results in cardiac pathology and persistence of embryonic splice isoforms.

Authors:  Donald M Dixon; Jongkyu Choi; Ayea El-Ghazali; Sun Young Park; Kenneth P Roos; Maria C Jordan; Michael C Fishbein; Lucio Comai; Sita Reddy
Journal:  Sci Rep       Date:  2015-03-12       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.